Brian Corvese

Sits on 2 boards. Last updated September 28, 2026

Time on boards

Boards served
2
Current seats
2
Board service
6 years
Director since
2023

6 years of board service in total across 2 boards, counting each seat separately. Longest: MiNK Therapeutics Inc., 3 years.

3 years · Since 2023
Agenus Inc. Director
2 years · Since 2024

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Sep 1, 2026 MiNK Therapeutics Inc. Grant or award +1,633 $10.95 $17,881
Jun 1, 2026 MiNK Therapeutics Inc. Grant or award +1,444 $12.38 $17,877
Mar 2, 2026 MiNK Therapeutics Inc. Grant or award +1,640 $10.90 $17,876
Dec 1, 2025 MiNK Therapeutics Inc. Grant or award +1,612 $11.09 $17,877
Sep 2, 2025 MiNK Therapeutics Inc. Grant or award +1,290 $13.86 $17,879
Jun 2, 2025 MiNK Therapeutics Inc. Grant or award +2,494 $7.17 $17,882
Mar 3, 2025 MiNK Therapeutics Inc. Grant or award +2,033 $8.79 $17,870
Dec 1, 2024 MiNK Therapeutics Inc. Grant or award +24,400 $0.73 $17,812
Sep 3, 2024 MiNK Therapeutics Inc. Grant or award +21,802 $0.82 $17,878
Jun 3, 2024 MiNK Therapeutics Inc. Grant or award +17,967 $0.99 $17,787
Mar 1, 2024 MiNK Therapeutics Inc. Grant or award +18,816 $0.95 $17,875
Dec 1, 2023 MiNK Therapeutics Inc. Grant or award +17,188 $1.04 $17,876
Sep 1, 2023 MiNK Therapeutics Inc. Grant or award +12,244 $1.46 $17,876
Jun 1, 2023 MiNK Therapeutics Inc. Grant or award +10,157 $1.76 $17,876
Mar 1, 2023 MiNK Therapeutics Inc. Grant or award +8,553 $2.09 $17,876

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.